Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Investment Securities: 2019-2024

Historic Gains from Investment Securities for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to -$887000.0.

  • Agilon Health's Gains from Investment Securities rose 81213.87% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 70996.88%. This contributed to the annual value of -$887000.0 for FY2024, which is 12193.37% down from last year.
  • Per Agilon Health's latest filing, its Gains from Investment Securities stood at -$887000.0 for FY2024, which was down 12193.37% from $4.0 million recorded in FY2023.
  • Over the past 5 years, Agilon Health's Gains from Investment Securities peaked at $4.0 million during FY2023, and registered a low of -$3.0 million during FY2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$58000.0 (2021), whereas its average is $57600.0.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 502586.21% in 2022, then surged by 23602.42% in 2023.
  • Agilon Health's Gains from Investment Securities (Annual) stood at $162000.0 in 2020, then tumbled by 135.8% to -$58000.0 in 2021, then crashed by 5025.86% to -$3.0 million in 2022, then skyrocketed by 236.02% to $4.0 million in 2023, then tumbled by 121.93% to -$887000.0 in 2024.
  • Its Gains from Investment Securities stands at -$887000.0 for FY2024, versus $4.0 million for FY2023 and -$3.0 million for FY2022.